Sign Up to like & get
recommendations!
0
Published in 2023 at "AntiCancer Research"
DOI: 10.21873/anticanres.16395
Abstract: Background/Aim: Nedaplatin (NDP)/5-fluorouracil (5-FU) combination therapy frequently causes severe neutropenia and febrile neutropenia (FN). However, there is no consensus on the risk factors for FN caused by NDP/5-FU combination therapy. Mouse models of cancer cachexia…
read more here.
Keywords:
combination therapy;
combination;
ndp combination;
febrile neutropenia ... See more keywords